The role of methylation of 9 miRNA genes in the pathogenesis of metastatic clear cell renal cell carcinoma was determined by quantitative methylation-specific PCR (MS-PCR). For 5 genes (MIR125B-1, MIR137, MIR193A, MIR34B/C, and MIR375), a significant correlation of high methylation level with late (III-IV) stages, large size (T3+T4) of the tumor, and metastasis to lymph nodes and/or distant organs was revealed. For another group of genes (MIR125B-1, MIR1258, MIR193A, MIR34B/C, and MIR375), a statistically significant correlation of high methylation level with loss of differentiation in the tumor (G3-G4) was found, and the opposite pattern was found for MIR203A. A total of 7 microRNA genes (MIR125B-1, MIR1258, MIR137, MIR193A, MIR203A, MIR34B/C, and MIR375) were identified, the methylation of which is associated with the progression of metastatic clear cell renal cell carcinoma. For 6 of them (except MIR34B/C) these data were obtained for the first time. Thus, new factors of the development and progression of clear cell renal cell carcinoma were identified as potential biomarkers for the early diagnosis and prognosis of metastatic clear cell renal cell carcinoma.
Similar content being viewed by others
References
Dyba T, Randi G, Bray F, Martos C, Giusti F, Nicholson N, Gavin A, Flego M, Neamtiu L, Dimitrova N, Negrão Carvalho R, Ferlay J, Bettio M. The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers. Eur. J. Cancer. 2021;157:308-347. doi: https://doi.org/10.1016/j.ejca.2021.07.039
Zaridze DG, Kaprin AD, Stilidi IS. Dynamics of morbidity and mortality from malignant tumors in Russia. Voprosy Onkol. 2018;64(5):578-591. Russian. doi: https://doi.org/10.37469/0507-3758-2018-64-5-578-591
Ricketts CJ, De Cubas AA, Fan H, Smith CC, Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, Bottaro DP, Choueiri TK, Gibbs RA, Godwin AK, Haake S, Hakimi AA, Henske EP, Hsieh JJ, Ho TH, Kanchi RS, Krishnan B, Kwiatkowski DJ, Lui W, Merino MJ, Mills GB, Myers J, Nickerson ML, Reuter VE, Schmidt LS, Shelley CS, Shen H, Shuch B, Signoretti S, Srinivasan R, Tamboli P, Thomas G, Vincent BG, Vocke CD, Wheeler DA, Yang L, Kim WY, Robertson AG; Cancer Genome Atlas Research Network, Spellman PT, Rathmell WK, Linehan WM. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018;23(1):313-326.e5. doi: https://doi.org/10.1016/j.celrep.2018.03.075
Popławski P, Bogusławska J, Hanusek K, Piekiełko-Witkowska A. Nucleolar proteins and non-coding RNAs: roles in renal cancer. Int. J. Mol. Sci. 2021;22(23):13126. doi: https://doi.org/10.3390/ijms222313126
Öztürk H. Bilateral synchronous adrenal metastases of renal cell carcinoma: A case report and review of the literature. Oncol. Lett. 2015;9(4):1897-1901. doi: https://doi.org/10.3892/ol.2015.2915
Costantino C, Thomas GV, Ryan C, Coakley FV, Troxell ML. Metastatic renal cell carcinoma without evidence of a renal primary. Int. Urol. Nephrol. 2016;48(1):73-77. doi: https://doi.org/10.1007/s11255-015-1145-3
Alecki C, Vera M. Role of nuclear non-canonical nucleic acid structures in organismal development and adaptation to stress conditions. Front. Genet. 2022;13:823241. doi: https://doi.org/10.3389/fgene.2022.823241
Braga EA, Fridman MV, Loginov VI, Dmitriev AA, Morozov SG. Molecular mechanisms in clear cell renal cell carcinoma: role of miRNAs and hypermethylated miRNA genes in crucial oncogenic pathways and processes. Front. Genet. 2019;10:320. doi: https://doi.org/10.3389/fgene.2019.00320
Hanahan D. Rethinking the war on cancer. Lancet. 2014;383:558-563. doi: https://doi.org/10.1016/S0140-6736(13)62226-6
Pfeifer GP. Defining driver DNA methylation changes in human cancer. Int. J. Mol. Sci. 2018;19(4):1166. doi: https://doi.org/10.3390/ijms19041166
TNM Classification of Malignant Tumours. Brierley JD, Gospodarowicz MK, Wittekind C, eds. Oxford; Hoboken, 2017.
Loginov VI, Burdennyy AM, Filippova EA, Pronina IV, Lukina SS, Kazubskaya TP, Karpukhin AV, Khodyrev DS, Braga EA. Aberrant methylation of 21 microRNA genes in breast cancer: sets of genes associated with progression and a system of markers for predicting metastasis. Bull. Exp. Biol. Med. 2021;172(1):67-71. doi: https://doi.org/10.1007/s10517-021-05333-x
Apanovich NV, Loginov VI, Filippova EA, Khodyrev DS, Burdennyy AM, Pronina IV, Ivanova NA, Lukina SS, Kazubskaya TP, Matveev VB, Karpukhin AV, Braga EA. Methylation of a group of microRNA genes: markers of renal cell carcinoma metastasis. Onkourologiya. 2020;16(4):32-38. Russian. doi: https://doi.org/10.17650/1726-9776-2020-16-4-32-38
Filippova EA, Pronina IV, Lukina SS, Kazubskaya TP, Braga EA, Burdennyi AM, Loginov VI. Relationship of the Levels of microRNA gene methylation with the level of their expression and pathomorphological characteristics of breast cancer. Bull. Exp. Biol. Med. 2021;171(6):764-769. doi: https://doi.org/10.1007/s10517-021-05312-2
Loginov VI, Pronina IV, Filippova EA, Burdennyy AM, Lukina SS, Kazubskaya TP, Uroshlev LA, Fridman MV, Brovkina OI, Apanovich NV, Karpukhin AV, Stilidi IS, Kushlinskii NE, Dmitriev AA, Braga EA. Aberrant methylation of 20 miRNA genes specifically involved in various steps of ovarian carcinoma spread: from primary tumors to peritoneal macroscopic metastases. Int. J. Mol. Sci. 2022;23(3):1300. doi: https://doi.org/10.3390/ijms23031300.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 175, No. 2, pp. 215-219, February, 2023
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ivanova, N.A., Burdennyi, A.M., Lukina, S.S. et al. The Role of Methylation of a Group of microRNA Genes in the Pathogenesis of Metastatic Renal Cell Carcinoma. Bull Exp Biol Med 175, 249–253 (2023). https://doi.org/10.1007/s10517-023-05844-9
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-023-05844-9